A case of immunoglobulin G4-related kidney disease manifesting after dipeptidyl peptidase-4 inhibitor treatment

CEN Case Rep. 2024 Dec;13(6):565-572. doi: 10.1007/s13730-024-00889-9. Epub 2024 May 27.

Abstract

A 68-year-old man with type 2 diabetes mellitus was admitted with decreased renal function. He had high IgG4 (1070 mg/dL) and hypocomplementemia (CH50, 25 U/mL). Kidney biopsy showed tubulointerstitial nephritis with IgG4-positive plasma cell infiltration. Four years later, a second kidney biopsy revealed a new manifestation of membranous nephropathy and tubulointerstitial nephritis with exacerbated fibrosis formation. Six years later, the patient developed bullous pemphigoid, which was thought to be caused by DPP4 inhibitors, so DPP4 inhibitor treatment was discontinued. The use of DPP4 inhibitors correlated with changes in renal function, and the patient was diagnosed with IgG4-related kidney disease related to DPP4 inhibitors.

Keywords: Dipeptidyl peptidase-4 (DPP4) inhibitors; IgG4-related kidney disease; IgG4-related tubulointerstitial nephritis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Biopsy
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Dipeptidyl-Peptidase IV Inhibitors* / adverse effects
  • Dipeptidyl-Peptidase IV Inhibitors* / therapeutic use
  • Glomerulonephritis, Membranous / diagnosis
  • Glomerulonephritis, Membranous / drug therapy
  • Glomerulonephritis, Membranous / pathology
  • Humans
  • Immunoglobulin G / adverse effects
  • Immunoglobulin G4-Related Disease* / complications
  • Immunoglobulin G4-Related Disease* / diagnosis
  • Immunoglobulin G4-Related Disease* / drug therapy
  • Kidney / pathology
  • Male
  • Nephritis, Interstitial / chemically induced
  • Nephritis, Interstitial / diagnosis
  • Nephritis, Interstitial / pathology
  • Pemphigoid, Bullous / chemically induced
  • Pemphigoid, Bullous / diagnosis
  • Pemphigoid, Bullous / drug therapy
  • Pemphigoid, Bullous / pathology

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Immunoglobulin G